Cargando…

Exploring the medication duration based on the effect of traditional Chinese medicine on postoperative stage I-III colorectal patients: a retrospective cohort study

PURPOSE: To clarify the effect of tradional Chinese medicine (TCM) on different stage patients and to explore medication duration based on survival analysis. RESULTS: 523 and 294 patients were respectively in the TCM group and the control group. For all patients, 6-year disease-free survival (DFS) w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Qi, Liu, Shanshan, Li, Wen, Zong, Shaoqi, Han, Susu, Yang, Wei, Li, Hongjia, Hou, Fenggang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355114/ https://www.ncbi.nlm.nih.gov/pubmed/28086238 http://dx.doi.org/10.18632/oncotarget.14567

Ejemplares similares

Clinicopathological, prognostic and predictive value of CD166 expression in colorectal cancer: a meta-analysis
por: Han, Susu, et al.
Publicado: (2017)

Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis
por: Han, Susu, et al.
Publicado: (2017)

Yi Ai Fang, a traditional Chinese herbal formula, impacts the vasculogenic mimicry formation of human colorectal cancer through HIF-1α and epithelial mesenchymal transition
por: Hou, Fenggang, et al.
Publicado: (2016)

A Chinese Herbal Formula Suppresses Colorectal Cancer Migration and Vasculogenic Mimicry Through ROS/HIF-1α/MMP2 Pathway in Hypoxic Microenvironment
por: Zong, Shaoqi, et al.
Publicado: (2020)

Hypoxia-induced vasculogenic mimicry formation in human colorectal cancer cells: Involvement of HIF-1a, Claudin-4, and E-cadherin and Vimentin
por: Li, Wen, et al.
Publicado: (2016)

MicroRNAs and angiogenesis: a new era for the management of colorectal cancer
por: Tang, Yufei, et al.
Publicado: (2021)

Prevention of cisplatin-based chemotherapy-induced delayed nausea and vomiting using triple antiemetic regimens: a mixed treatment comparison
por: Shi, Qi, et al.
Publicado: (2016)

DNMT1, DNMT3A and DNMT3B Polymorphisms Associated With Gastric Cancer Risk: A Systematic Review and Meta-analysis
por: Li, Hongjia, et al.
Publicado: (2016)

Prognostic Value of CD133 and SOX2 in Advanced Cancer
por: Han, Susu, et al.
Publicado: (2019)

Application of Traditional Chinese Medicines in Postoperative Abdominal Adhesion
por: Wu, Fuling, et al.
Publicado: (2020)

Prognostic Value of CD44 and Its Isoforms in Advanced Cancer: A Systematic Meta-Analysis With Trial Sequential Analysis
por: Han, Susu, et al.
Publicado: (2019)

Prognostic value of ALDH1 and Nestin in advanced cancer: a systematic meta-analysis with trial sequential analysis
por: Han, Susu, et al.
Publicado: (2019)

Right- and left-sided colorectal cancers respond differently to traditional Chinese medicine
por: Liu, Shan-Shan, et al.
Publicado: (2017)

Exploration of predictive biomarkers for postoperative recurrence of stage II/III colorectal cancer using genomic sequencing
por: Kishigami, Fumishi, et al.
Publicado: (2022)

Optimal postoperative surveillance strategies for stage III colorectal cancer
por: Park, Min Young, et al.
Publicado: (2021)

Postoperative serum interleukin-6 levels correlate with survival in stage I-III colorectal cancer
por: Feng, Shouhan, et al.
Publicado: (2023)

Traditional Chinese Medicine and Colorectal Cancer: Implications for Drug Discovery
por: Sun, Qiang, et al.
Publicado: (2021)

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
por: Chen, Gong, et al.
Publicado: (2021)

Efficacy and safety of traditional Chinese medicine nursing intervention in postoperative patients after gastrectomy
por: Fan, Lizhi, et al.
Publicado: (2023)

Perspectives of traditional Chinese medicine in pancreas protection for acute pancreatitis
por: Li, Jun, et al.
Publicado: (2017)

An Exploration of Traditional Chinese Medicinal Plants with Anti-Inflammatory Activities
por: Fan, Chao, et al.
Publicado: (2017)

A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer
por: Xin, Cheng, et al.
Publicado: (2023)

Chinese science: explorations of an ancient tradition
por: Sivin, Nathan, et al.
Publicado: (1973)

Postoperative Fasting Blood Glucose Predicts Prognosis in Stage I-III Colorectal Cancer Patients Undergoing Resection
por: Xu, Rui, et al.
Publicado: (2020)

Integrative analysis and identification of key elements and pathways regulated by Traditional Chinese Medicine (Yiqi Sanjie formula) in colorectal cancer
por: Wan, Xianghui, et al.
Publicado: (2022)

Survival nomograms for stage III colorectal cancer
por: Li, Chenglong, et al.
Publicado: (2018)

Exploring the ‘cold/hot’ properties of traditional Chinese medicine by cell temperature measurement
por: Yu, Suyun, et al.
Publicado: (2020)

Effects of Traditional Chinese Medicine and its Active Ingredients on Drug-Resistant Bacteria
por: Li, Jimin, et al.
Publicado: (2022)

The Challenges of Ethical Review in Clinical Research of Traditional Chinese Medicine
por: Zhang, Jie, et al.
Publicado: (2021)

In silico Identification and Mechanism Exploration of Hepatotoxic Ingredients in Traditional Chinese Medicine
por: Wu, Qihui, et al.
Publicado: (2019)

Model exploration for discovering COVID-19 targeted traditional Chinese medicine
por: Sun, Yuting, et al.
Publicado: (2022)

Traditional chinese medicine in coronary microvascular disease
por: Yang, Zhihua, et al.
Publicado: (2022)

Traditional Chinese medicine-induced treatment in colitis-associated colorectal cancer
por: Yang, Yuewen, et al.
Publicado: (2023)

Meta-analysis of the traditional Chinese medicine care model in relieving postoperative pain in patients with anorectal diseases
por: Li, Peiyao, et al.
Publicado: (2023)

GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy
por: Lin, Wey-Ran, et al.
Publicado: (2016)

Postoperative prophylactic hepatic arterial infusion chemotherapy for stage III colorectal cancer: a retrospective study
por: Wang, Yao, et al.
Publicado: (2016)

Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients
por: Yasui, Kohei, et al.
Publicado: (2020)

Impact of Postoperative Naples Prognostic Score to Predict Survival in Patients with Stage II–III Colorectal Cancer
por: Park, Su Hyeong, et al.
Publicado: (2023)

The potential contributions of traditional Chinese medicine to emergency medicine
por: He, Jun, et al.
Publicado: (2013)

Postoperative Adjuvant Chemoradiotherapy on the Survival of Stage III Gastric Cancer
por: Li, Chao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g208ll9h0k1qhjbna31gasv687